Clinical trial
Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine in HIV-exposed and HIV-unexposed South African Children
NCT03330171 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine in HIV-exposed and HIV-unexposed South African Children
- Lead sponsor
- University of Witwatersrand, South Africa
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 10, 2017
- Completion date
- December 1, 2022
- Enrollment
- 278 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis a, measles, varicella